Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
474.26%Depreciation and Amortization Margin
VS
Market
Sector
Industry
History
$ 26.76Close
$ 21.77 - $ 66.83 52-Week Range
Ticker Information
Ticker
JANXCompany Name
JANUX THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQJANUX THERAPEUTICS INC - Depreciation and Amortization Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
JANX - DepAmor % Historical data
| Date | Depreciation, Amortization & Accretion | Depreciation and Amortization Margin | Revenues |
|---|---|---|---|
| 6/30/2025 | $ 2.08M | 474.26% | $ 439K |
| 3/31/2025 | $ 2.05M | 21.93% | $ 9.34M |
| 12/31/2024 | $ 2.06M | 19.46% | $ 10.59M |
| 9/30/2024 | $ 2.08M | 15.93% | $ 13.05M |
| 6/30/2024 | $ 2.07M | 13.68% | $ 15.13M |
| 3/31/2024 | $ 2.03M | 27.91% | $ 7.29M |
| 12/31/2023 | $ 1.96M | 24.19% | $ 8.08M |
| 9/30/2023 | $ 1.83M | 21.58% | $ 8.47M |
| 6/30/2023 | $ 1.58M | 20.3% | $ 7.76M |
| 3/31/2023 | $ 1.21M | 13.37% | $ 9.07M |
Key Performance Insights, Last 5 Years
- JANUX THERAPEUTICS INC's latest trailing twelve months (TTM) DepAmor % stands at 3.11%.
- Over the past 5 years, JANUX THERAPEUTICS INC's average DepAmor % has been 45.35%.
- The median DepAmor % for JANUX THERAPEUTICS INC during this period was 15.93%
- JANUX THERAPEUTICS INC reached its highest DepAmor % over the past 5 years at 474.26%.
- The lowest DepAmor % recorded by JANUX THERAPEUTICS INC in the same timeframe 3.11%
JANUX THERAPEUTICS INC's DepAmor % vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
DepAmor % Benchmarks
Similar metrics to Revenues:
- Research and Development Margin - [Calculation] The company’s research and development expenses [RnD] expressed as a percentage of [Revenue].
- Interest Expense Margin - [Calculation] The company’s interest expenses [IntExp] expressed as a percentage of [Revenue].
- Stock Based Compensation Margin - [Calculation] The company’s stock-based compensation [SbComp] expressed as a percentage of [Revenue].
- Operating Cash Flow Margin - [Calculation] The company's operating cash flow [NCFO] expressed as a percentage of [Revenue].
- Depreciation, Amortization & Accretion - [Cash Flow Statement] A component of operating cash flow [NCFO] representing the aggregate net amount of depreciation, amortization, and accretion recognized during an accounting period. As a non-cash item, the net amount is added back to net income when calculating cash provided by operations.
Definition of Depreciation and Amortization Margin
[Calculation] The company’s deprecation and amortization [DepAmor] expressed as a percentage of [Revenue].DepAmor / Revenues
(=) DepAmor % DepAmor % for JANUX THERAPEUTICS INC is calculated as follows: DepAmor [ $ 113K ] / Revenues [ $ 3.64M ]
(=) DepAmor % [ 3.11% ] JANX - Depreciation and Amortization Margin, Last 5 years
3.11%
Minimum
Dec 31, 2021
474.26%
Maximum
Jun 30, 2025
45.35%
Average
15.93%
Median
DepAmor % Benchmark AnalysisMarket
The chart above depicts the distribution of DepAmor % for companies in the Total Stock Market. The average DepAmor % of the companies is 5.85% with a standard deviation of 5.13%.
The following table provides additional summary stats:
DepAmor % in the Market:
| filtered constituents | 3.32K |
|---|---|
| min | -6.41% |
| max | 22.52% |
| average | 5.85% |
| median | 4.2% |
| std | 5.13% |